Related Experiment Video
Updated: Nov 20, 2025

09:58
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
14.0K
Detection of aberrant splicing events in RNA-seq data using FRASER
Christian Mertes1, Ines F Scheller1,2, Vicente A Yépez1,3
1Department of Informatics, Technical University of Munich, Garching, Germany.
Nature Communications
|January 23, 2021
Summary
FRASER is a new algorithm that detects aberrant splicing, a cause of rare diseases, using RNA sequencing. It identifies more splicing events, including intron retention, improving rare disease diagnostics.
Area of Science:
- Genomics
- Computational Biology
- Rare Diseases
Background:
- Aberrant splicing is a significant cause of rare genetic diseases.
- Predicting aberrant splicing solely from genome sequences is often inconclusive.
- RNA sequencing offers a complementary approach for detecting aberrant splicing.
Purpose of the Study:
- To develop FRASER, an algorithm for detecting aberrant splicing events from RNA sequencing data.
- To improve the identification of splicing alterations in rare disease diagnostics.
Main Methods:
- FRASER algorithm development for RNA sequencing data analysis.
- Incorporation of alternative splicing and intron retention event detection.
- Implementation of latent confounder control and count distribution-based analysis.
- Application of multiple testing correction for robust statistical inference.
Main Results:
- FRASER detects both alternative splicing and intron retention, doubling the number of aberrant events identified.
- A pathogenic intron retention event in MCOLN1 causing mucolipidosis was identified.
- FRASER significantly reduces false positive calls compared to z-score cutoffs.
- Reprioritization of a pathogenic aberrant exon truncation in TAZ using FRASER.
Conclusions:
- FRASER enhances the detection of aberrant splicing events, including intron retention.
- The algorithm improves the diagnostic yield for rare diseases by identifying pathogenic splicing alterations.
- FRASER offers a robust, user-friendly, and freely available tool for rare disease diagnostics.
Related Concept Videos
RNA Splicing
59.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
59.0K
RNA-seq
11.1K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.1K
Alternative RNA Splicing
23.8K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
23.8K
Alternative RNA Splicing
4.4K
4.4K
Pre-mRNA Processing: RNA Splicing
6.1K
6.1K
Nonsense-mediated mRNA Decay
11.3K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.3K

